01
Why batch-level information matters
A batch that remains saleable under the seller’s quality procedures and applicable requirements can become commercially time-sensitive before its labelled expiry. Presenting the exact lot privately to eligible demand may reduce avoidable stock write-off. The seller enters a confidential supplier net price, while the buyer assesses a separate final product price that includes the fixed 6.5% marketplace fee. This is a controlled matching opportunity—not a guaranteed sale or a route for expired stock.
A medicine name does not describe a tradeable batch. Strength, dosage form, pack size, quantity, expiry, origin and storage conditions can materially change whether inventory is suitable for a buyer and route.
Short-dated does not have one universal definition. The acceptable remaining shelf life depends on the buyer, destination, transport time, product and applicable requirements. The actual expiry should therefore be shown rather than replaced by a vague label.
02
Minimum information for an available lot
- Exact brand or ingredient, strength, dosage form and pack size
- Product reference such as PZN where available
- Real available quantity and allocation period
- Batch or lot number and expiry month
- Country of origin and current storage location where required for review
- Storage profile and transport-control requirements
- Supplier net price per pack and applicable commercial conditions
- Traceability, quality and transaction documents available on request
03
A safer route from listing to decision
- 01
Use a verified seller account
Only an eligible and approved seller should be able to present stock or answer demand.
- 02
Attach the lot to the exact pack
This prevents a brand-level listing from hiding a strength, form or pack mismatch.
- 03
Keep sensitive data private
Quantity, role-specific prices and counterparty details should remain inside approved B2B accounts. Sellers see supplier net prices; buyers see fee-inclusive final product prices.
- 04
Review a buyer request
The seller confirms or declines a requested quantity before the route enters administrator review.
- 05
Complete wholesale review
The proposed product, parties, route and documents are assessed before acceptance.
- 06
Execute only under accepted terms
Final commercial documents govern invoice, settlement, transport and delivery. Transaction-specific logistics are calculated and itemised manually rather than added automatically by the marketplace.
04
Common failure modes to avoid
| Failure mode | Why it creates risk | Better control |
|---|---|---|
| Listing only a brand name | The strength, form or pack can be wrong. | Require selection of one exact medicine record. |
| Hiding the actual expiry | The buyer cannot assess remaining shelf life. | Display the expiry month and keep it current. |
| Treating reference data as stock | A database entry does not prove availability. | Require a seller-created, reviewed batch offer. |
| Publishing prices openly | Commercial information can be scraped or misused. | Restrict live offers to approved accounts. |
| Allowing direct contact during matching | Participants can bypass controls and audit records. | Keep communication and decisions in the authorised workflow. |
| Assuming a platform match is final | Authorisation and transaction conditions may still fail. | Require explicit review and acceptance. |
05
PharmaBatch seller boundary
Verified seller access is limited to eligible legal entities established in the EU-27 or the United Kingdom and includes the buying workflow. Buyer-only accounts cannot list batches or respond to RFQs.
PharmaBatch organises the private listing and decision trail. It does not buy, own, store or distribute the medicines. Under the operating model, River Pharma GmbH considers the proposed wholesale transaction and becomes the contracting and medicine-invoicing party only where it accepts that transaction.
06
Frequently asked questions
Does a medicine-directory entry prove stock?
No. A directory record identifies a medicine presentation. A separate seller-created batch offer is required to state actual availability, quantity, supplier net price and expiry. Approved buyers see the resulting final product price including the marketplace fee.
Can any company list surplus stock?
No. On PharmaBatch, selling tools are limited to approved verified sellers that meet the EU-27 or United Kingdom legal-entity eligibility and seller-review requirements.
Is short-dated stock automatically unsuitable?
No. Suitability depends on the exact expiry, destination, transport time, buyer acceptance criteria and applicable requirements. These factors must be reviewed for the specific transaction.
Does PharmaBatch guarantee a batch will be sold?
No. A listing or buyer request does not guarantee availability, acceptance or execution.
07
Primary sources
Regulatory statements on this page are grounded in the following official sources. Always check the current record and guidance for a real transaction.